[go: up one dir, main page]

WO2002003848A8 - Method for opening the blood-brain barrier - Google Patents

Method for opening the blood-brain barrier

Info

Publication number
WO2002003848A8
WO2002003848A8 PCT/US2001/019654 US0119654W WO0203848A8 WO 2002003848 A8 WO2002003848 A8 WO 2002003848A8 US 0119654 W US0119654 W US 0119654W WO 0203848 A8 WO0203848 A8 WO 0203848A8
Authority
WO
WIPO (PCT)
Prior art keywords
blood
brain barrier
opening
sugar
nervous system
Prior art date
Application number
PCT/US2001/019654
Other languages
French (fr)
Other versions
WO2002003848A2 (en
WO2002003848A3 (en
Inventor
Albert T Naito
Original Assignee
Albert T Naito
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert T Naito filed Critical Albert T Naito
Priority to JP2002508310A priority Critical patent/JP2004502706A/en
Priority to EP01950344A priority patent/EP1298994A2/en
Priority to AU2001271345A priority patent/AU2001271345A1/en
Publication of WO2002003848A2 publication Critical patent/WO2002003848A2/en
Publication of WO2002003848A3 publication Critical patent/WO2002003848A3/en
Publication of WO2002003848A8 publication Critical patent/WO2002003848A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oral administritration of sugar opens the blood-brain barrier and permits a co-administered chemical compound to enter the central nervous system in a higher amount than occurs without co-administration of the sugar. The increased amount that enters the central nervous system results in an increased biologic effect of the chemical compound.
PCT/US2001/019654 2000-07-10 2001-06-19 Method for opening the blood-brain barrier WO2002003848A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2002508310A JP2004502706A (en) 2000-07-10 2001-06-19 How to open the blood-brain barrier
EP01950344A EP1298994A2 (en) 2000-07-10 2001-06-19 Method for opening the blood-brain barrier
AU2001271345A AU2001271345A1 (en) 2000-07-10 2001-06-19 Method for opening the blood-brain barrier

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61321200A 2000-07-10 2000-07-10
US09/613,212 2000-07-10

Publications (3)

Publication Number Publication Date
WO2002003848A2 WO2002003848A2 (en) 2002-01-17
WO2002003848A3 WO2002003848A3 (en) 2002-08-15
WO2002003848A8 true WO2002003848A8 (en) 2003-11-06

Family

ID=24456335

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019654 WO2002003848A2 (en) 2000-07-10 2001-06-19 Method for opening the blood-brain barrier

Country Status (4)

Country Link
EP (1) EP1298994A2 (en)
JP (1) JP2004502706A (en)
AU (1) AU2001271345A1 (en)
WO (1) WO2002003848A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003327528A (en) * 2002-03-04 2003-11-19 Pharmafoods Kenkyusho:Kk Immunocompetence-improving composition
WO2004039940A2 (en) * 2002-05-14 2004-05-13 Bristol-Myers Squibb Company Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof
US8796441B2 (en) 2005-04-13 2014-08-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human sweet and umami taste receptor variants
US20070072795A1 (en) * 2005-09-28 2007-03-29 Anton Haselbeck Treatment of neurodegenerative disorders
JP6763780B2 (en) * 2014-05-12 2020-09-30 ザ・ジョンズ・ホプキンス・ユニバーシティー Manipulation of synthetic brain penetrating gene vectors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643773A (en) * 1984-03-09 1987-02-17 A. E. Staley Manufacturing Company Crystallization of fructose utilizing a mixture of alcohols
US4897380A (en) * 1985-08-30 1990-01-30 Pollack Robert L Method and composition for relieving dietary-related disorders
JP3051413B2 (en) * 1989-07-20 2000-06-12 アルバート・ティー・ナイトー Substances that cross the blood-brain barrier
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition

Also Published As

Publication number Publication date
EP1298994A2 (en) 2003-04-09
JP2004502706A (en) 2004-01-29
WO2002003848A2 (en) 2002-01-17
AU2001271345A1 (en) 2002-01-21
WO2002003848A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2001279042A1 (en) Blood-organ barrier opening
ZA200202480B (en) Oral dosage forms.
AU2001261144A1 (en) Ultrasonic dosage device and method
IL164857A (en) 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them
MXPA03004504A (en) Oral treatment systems.
WO2005065318A3 (en) Effervescent oral opiate dosage form
AU2002236647A1 (en) Method and device for administering medication and/or placebo
AU2002222106A1 (en) Modular barrier
AU2002320057A1 (en) Herbal composition for improving oral hygiene, and methods of using same
AU2002241736A1 (en) Method for preventing or treating pain by administering an endothelin antagonist
AU2003223989A1 (en) System for orally administering active substances, vitamins and/or foodstuffs
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
ZA200108373B (en) Dental diet for reducing tartar.
AU2001269291A1 (en) Therapeutic acridone and acridine compounds
WO2002003848A8 (en) Method for opening the blood-brain barrier
AU2001295979A1 (en) Medicinal compositions, dose and method for treating malaria
AU2001272695A1 (en) Azithromocin monohydrate with lower hygroscopicity, preparation method and pharmaceutical compositions which include it
ZA200210361B (en) Method of administering bishosphonates.
HU229583B1 (en) Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
AU2002222079A1 (en) Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
AU2001243681A1 (en) Event contest method
AU2001231107A1 (en) Improved lactational
AU2002221819A1 (en) Passivation method
AU2001282144A1 (en) Anti-exit and collision barrier
AUPR697701A0 (en) Safety barrier

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001950344

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001950344

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 03/2002 DUE TO A TECHNICAL PROBLEM AT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION.

Free format text: IN PCT GAZETTE 03/2002 DUE TO A TECHNICAL PROBLEM AT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION.

WWW Wipo information: withdrawn in national office

Ref document number: 2001950344

Country of ref document: EP